Objetivo
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
HORIZON-CL4-2022-DIGITAL-EMERGING-02
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinador
771 47 Olomouc
Chequia